Skip to menu Skip to content Skip to footer

2008

Journal Article

Adiponectin, skeletal muscle adiponectin receptor expression and insulin resistance following dexamethasone

Jang, Christina, Inder, Warrick J., Obeyesekere, Varuni R. and Alford, Frank P. (2008). Adiponectin, skeletal muscle adiponectin receptor expression and insulin resistance following dexamethasone. Clinical Endocrinology, 69 (5), 745-750. doi: 10.1111/j.1365-2265.2008.03242.x

Adiponectin, skeletal muscle adiponectin receptor expression and insulin resistance following dexamethasone

2004

Journal Article

The need for a large-scale trial of fibrate therapy in diabetes: the rationale and design of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. [ISRCTN64783481]

Barter, P., Best, J., Colman, P., d'Emden, M., Davis, T., Drury, P., Ehnholm, C., Glasziou, P., Hunt, D., Keech, A., Kesaniemi, Y. A., Laakso, M., Scott, R., Simes, R. J., Sullivan, D., Taskinen, M-R, Whiting, M., Ansquer, J-C, Fraitag, B., Anderson, N., Hankey, G., Hunt, D., Lehto, S., Mann, S., Romo, M., Li, L. P., Hennekens, C., MacMahon, S., Pocock, S. ... Aubonnet, P. (2004). The need for a large-scale trial of fibrate therapy in diabetes: the rationale and design of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. [ISRCTN64783481]. Cardiovascular Diabetology, 3 (1) 9. doi: 10.1186/1475-2840-3-9

The need for a large-scale trial of fibrate therapy in diabetes: the rationale and design of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. [ISRCTN64783481]